$143.95
5.173.73%
Last update: Nov 9, 4:04 PM
Veradermics Inc (MANE) Stock Price, Quote, News & History
MANENYSE
Veradermics reports positive Phase 2/3 trial data for its oral hair loss pill, paving the way for potential FDA approval. MANE shares rise.
You can purchase shares of Veradermics (NYSE:MANE) through any online brokerage.
Other companies in Veradermics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Veradermics has a consensus price target of $167.17.
The stock price for Veradermics (NYSE: MANE) is $143.95 last updated November 9, 2026 at 4:04 PM EST.
There are no upcoming dividends for Veradermics.
Veradermics does not have any upcoming earnings scheduled.
There is no upcoming split for Veradermics.
Veradermics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating...
